Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.
Rudick
R A
RA
Goodkin
D E
DE
Jacobs
L D
LD
Cookfair
D L
DL
Herndon
R M
RM
Richert
J R
JR
Salazar
A M
AM
Fischer
J S
JS
Granger
C V
CV
Simon
J H
JH
Alam
J J
JJ
Simonian
N A
NA
Campion
M K
MK
Bartoszak
D M
DM
Bourdette
D N
DN
Braiman
J
J
Brownscheidle
C M
CM
Coats
M E
ME
Cohan
S L
SL
Dougherty
D S
DS
Kinkel
R P
RP
Mass
M K
MK
Munschauer
F E
FE
Priore
R L
RL
Pullicino
P M
PM
Scherokman
B J
BJ
Weistock-Guttman
B
B
Whitham
R H
RH
D017326:Clinical Trials, Phase III as Topic / Q000266:history; D004185:Disability Evaluation; D005260:Female; D049673:History, 20th Century; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000266:history* / Q000627:therapeutic use; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy / Q000266:history*; D016032:Randomized Controlled Trials as Topic / Q000266:history
D016899:Interferon-beta; D000068556:Interferon beta-1a